查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009005

中風治療市場報告：按類型、應用、最終用戶和地區分類（2026-2034 年）

Stroke Management Market Report by Type (Diagnostics, Therapeutics), Application (Ischemic Stroke, Haemorrhagic Stroke, and Others), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年全球中風治療市場規模達401億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到655億美元，2026年至2034年的複合年成長率為5.60%。推動市場成長的因素包括中風給醫療保健系統帶來的日益沉重的負擔、對以患者為中心的護理和個性化治療方案的日益重視，以及為改進中風管理技術和開發新治療方法而加大研發投入。

卒中管理是指採用綜合方法減輕卒中的影響及其長期後果。中風是一種由腦部血流受損引起的醫療急症。有效的卒中管理對於最大限度地減少腦損傷、改善患者預後和提高生活品質至關重要。快速且準確的診斷是卒中管理的關鍵。快速評估工具，例如 FAST（顏面神經麻痺、手臂無力、言語障礙、撥打急救電話時間），有助於識別中風症狀並及時進行醫療干預。電腦斷層掃描 (CT) 和磁振造影(MRI) 等影像學技術有助於確定中風的類型和位置。即時治療的重點是恢復腦部血流。對於缺血性中風，可以使用溶栓藥物，例如組織型胞漿素原原活化劑 (tPA) 或機械取栓術。對於出血性中風，可能需要手術干預以止血並減輕腦壓。卒中後管理包括復健治療，以恢復喪失的功能並預防進一步的殘疾。這可能包括物理治療、職業治療、語言治療和心理支持。醫生也可能開立藥物來控制高血壓、高膽固醇和抗凝血等風險因子。此外，預防措施對於降低中風復發風險至關重要。改善生活方式，例如健康飲食、規律運動、戒菸以及控制糖尿病和心房顫動等慢性疾病，對中風管理至關重要。中風治療和復健領域的持續研究和進展正在不斷改善中風管理策略和治療效果。

全球市場的主要驅動力是中風發病率的不斷上升。人口老化也是推動市場成長的重要因素。此外，診斷、影像和治療方法技術的進步也對市場產生了積極影響。大眾對中風徵兆和體徵的認知不斷提高，以及對及時治療重要性的認知不斷增強，也促進了市場成長。政府進行的中風預防和管理宣傳活動和措施也推動了市場擴張。針對中風管理程序和治療的優惠報銷政策獎勵了醫療服務提供者，從而推動了市場發展。此外，遠端醫療和遠距監測技術的快速普及使得遠距中風管理成為可能，擴大了市場覆蓋範圍。專業中風中心和設施的建立提高了中風管理能力，並進一步鞏固了市場地位。

中風管理市場的趨勢與促進因素：

慢性病盛行率增加

慢性病盛行率的上升正在推動市場發展。心血管疾病、糖尿病和高血壓等慢性病是中風的主要危險因子。隨著全球人口老化和久坐生活方式的盛行，這些慢性病的盛行率持續上升。因此，面臨中風風險的人也不斷增加。慢性病盛行率的上升也增加了對有效中風管理策略的需求。醫療專業人員和機構需要製定全面的中風預防計劃，並實施快速有效的治療通訊協定。此外，持續監測和管理慢性病以最大限度降低中風發作和復發的風險也日益重要。公共衛生計劃、宣傳宣傳活動和預防措施正在實施，以提高人們對慢性病與中風之間關聯的認知。這些計劃旨在促進早期發現、改善生活方式和堅持治療方案，最終減輕中風負擔，並刺激中風管理解決方案市場的發展。

個人對早期診斷和治療益處的認知不斷提高

大眾對早期診斷和治療益處的認知不斷提高，為市場帶來了光明的前景。隨著大眾對中風的徵兆、症狀和後果的了解不斷加深，人們也更加積極主動地尋求及時的醫療協助。這種意識的提高使人們能夠理解快速識別中風症狀並立即就醫的重要性。識別諸如突發麻木或無力、言語或理解困難以及劇烈頭痛等症狀，將促使人們毫不猶豫地尋求緊急醫療協助。早期診斷和及時治療對於最大限度地減少中風的影響和改善患者預後至關重要。隨著意識的增強，人們將採取更迅速的行動，從而實現更早的干涉，並有可能挽救生命的治療，例如溶栓治療和機械取栓術。提高公眾意識的宣傳活動包括公共衛生宣傳活動、教育活動和社區宣傳項目。這些努力旨在傳播有關中風預防、風險因素以及立即就醫必要性的知識。意識的提高將使人們能夠採取積極主動的措施，從而重振中風管理解決方案市場，並提高中風護理的整體品質。

推出新一代先進醫療設備和藥品

新型先進醫療設備和藥品的推出為市場帶來了許多機會。醫療設備和藥品領域的技術進步和持續創新正在革新中風治療，改善患者預後，並推動市場蓬勃發展。諸如先進影像、介入神經放射學和機器人輔助系統等新型醫療設備提高了中風診斷和治療的準確性和精確度。這些設備使醫護人員能夠快速有效地清除血栓，恢復腦部血流，並最大限度地減少腦損傷。此外，創新的復健設備和輔助技術也為中風患者的復健和恢復提供了支持。新藥和藥物療法的研發也對市場發展起了至關重要的作用。溶栓藥物、神經保護劑和抗血小板藥物顯著改善了中風的治療和預防。這些藥物旨在溶解血栓、保護腦細胞並控制危險因素，進而降低復發風險。此外，新型醫療設備和藥物的推出也帶來了中風管理模式轉移，實現了更精準的診斷、微創治療和標靶治療。這些進步正在改善患者照護，為醫療保健專業人員和製造商創造新的機會，並推動市場發展。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球中風治療市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 診斷
    • 主要部分
      • 電腦斷層掃描（電腦斷層掃描）
      • 磁振造影（MRI）
      • 頸動脈超音波檢查
      • 腦血管造影術
      • 心電圖（ECG）
      • 心臟超音波圖
      • 其他
  • 治療
    • 主要部分
      • 組織型胞漿素原原活化劑
      • 抗凝血劑
      • 抗血小板藥物
      • 抗高血壓藥物

第7章 市場區隔：依應用領域分類

  • 缺血性中風
  • 出血性中風
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Company
    • Cardinal Health
    • General Electric Company
    • GlaxoSmithKline plc
    • Medtronic plc
    • Merck & Co. Inc.
    • Siemens Healthineers AG（Siemens AG）
Product Code: SR112026A4313

The global stroke management market size reached USD 40.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.60% during 2026-2034. The rising burden of strokes on healthcare systems, the increasing focus on patient-centered care and personalized treatment plans, and the growing research and development efforts to improve stroke management techniques and develop new therapies are some of the factors propelling the market.

Stroke management involves a comprehensive approach to reduce the impact and long-term consequences of stroke, a medical emergency caused by disrupted blood flow to the brain. Effective stroke management is crucial to minimize brain damage, improve patient outcomes, and enhance quality of life. Prompt and accurate diagnosis is essential in stroke management. Quick assessment tools, such as the FAST acronym (Facial drooping, Arm weakness, Speech difficulties, Time to call emergency services), aid in identifying stroke symptoms and enabling timely medical intervention. Diagnostic imaging, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), helps determine the type and location of the stroke. Immediate treatment focuses on restoring blood flow to the brain. Clot-dissolving medications like tissue plasminogen activator (tPA) or mechanical thrombectomy may be used for ischemic stroke. Hemorrhagic stroke may require surgical interventions to stop bleeding and relieve pressure on the brain. Post-stroke management involves rehabilitation to restore lost functions and prevent disability. This may include physical therapy, occupational therapy, speech therapy, and psychological support. Medications to manage risk factors like high blood pressure, high cholesterol, and blood thinners may also be prescribed. Additionally, preventive measures are essential to reduce the risk of recurrent strokes. Lifestyle modifications such as a healthy diet, regular exercise, smoking cessation, and managing chronic conditions, such as diabetes or atrial fibrillation, are crucial to stroke management. Ongoing research and advancements in stroke treatment and rehabilitation continue to improve stroke management strategies and outcomes.

The global market is primarily driven by the growing incidence of strokes. In line with this, the increasing aging population is significantly contributing to the market. Furthermore, the rising technological advancements in diagnostics, imaging, and treatment options are positively influencing the market. The growing public awareness about the signs, symptoms, and importance of prompt stroke management is also catalyzing the market. Moreover, the government's campaigns and initiatives to address stroke prevention and management promote market expansion. Besides, the favorable reimbursement policies for stroke management procedures and treatments incentivize healthcare providers and propel the market. Additionally, the rapid adoption of telemedicine and remote monitoring technologies allows for remote stroke management and expands the market reach. The establishment of dedicated stroke centers and specialized facilities enhances stroke management capabilities and strengthens the market.

STROKE MANAGEMENT MARKET TRENDS/DRIVERS:

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases is fostering the market. Chronic diseases, such as cardiovascular diseases, diabetes, and hypertension, are major stroke risk factors. As the global population ages and lifestyles become more sedentary, the prevalence of these chronic conditions continues to increase. This results in a larger population at risk of experiencing strokes. The increasing prevalence of chronic diseases creates a greater demand for effective stroke management strategies. Healthcare providers and organizations are prompted to develop comprehensive stroke prevention programs and implement timely and efficient treatment protocols. Additionally, there is a growing need for ongoing monitoring and management of chronic conditions to minimize the risk of stroke occurrence or recurrence. Public health initiatives, education campaigns, and preventive measures are being implemented to raise awareness about the relationship between chronic diseases and strokes. These efforts aim to promote early detection, lifestyle modifications, and adherence to treatment regimens, ultimately reducing the burden of strokes and fueling the market for stroke management solutions.

Rising awareness among individuals regarding the benefits of early diagnosis and treatments

Rising awareness among individuals about the benefits of early diagnosis and treatments is creating a positive outlook for the market. As public knowledge about the signs, symptoms, and consequences of strokes improves, individuals are becoming more proactive in seeking timely medical attention. Increased awareness empowers individuals to recognize stroke symptoms promptly and understand the importance of seeking immediate medical help. Recognizing symptoms such as sudden numbness or weakness, difficulty speaking or understanding, and severe headache prompts individuals to seek emergency care without delay. Early diagnosis and prompt treatment are critical in minimizing the impact of strokes and improving patient outcomes. With greater awareness, individuals are more likely to act swiftly, leading to faster intervention and potentially life-saving treatments such as clot-dissolving medications or mechanical thrombectomy. Efforts to raise awareness include public health campaigns, educational initiatives, and community outreach programs. These endeavors aim to educate individuals about stroke prevention, risk factors, and the need for immediate medical intervention. By increasing awareness, individuals are empowered to take proactive measures, bolstering the market for stroke management solutions and improving overall stroke care.

Introduction of new and advanced devices and drugs

Introducing new and advanced devices and drugs offers numerous opportunities for the market. Technological advancements and continuous innovation in medical devices and pharmaceuticals have revolutionized stroke care, improving patient outcomes and catalyzing the market. New devices, such as advanced imaging, neuro-interventional, and robotic-assisted systems, have enhanced the accuracy and precision of stroke diagnosis and treatment. These devices enable healthcare providers to swiftly and effectively remove clots, restore blood flow to the brain, and minimize the extent of brain damage. Additionally, innovative rehabilitation devices and assistive technologies aid in stroke recovery and rehabilitation. The development of new drugs and pharmaceutical interventions has also played a vital role in driving the market. Thrombolytic drugs, neuroprotective agents, and antiplatelet medications have significantly improved stroke treatment and prevention. These drugs aim to dissolve clots, protect brain cells, and manage risk factors to reduce the likelihood of recurrent strokes. Moreover, introducing new devices and drugs has led to a paradigm shift in stroke management, enabling more precise diagnoses, minimally invasive treatments, and targeted therapies. These advancements enhance patient care and create new opportunities for healthcare providers and manufacturers, propelling the market.

STROKE MANAGEMENT INDUSTRY SEGMENTATION:

Breakup by Type:

  • Diagnostics
    • Computed Tomography Scan (CT Scan)
    • Magnetic Resonance Imaging (MRI)
    • Carotid Ultrasound
    • Cerebral Angiography
    • Electrocardiography
    • Echocardiography
    • Others
  • Therapeutics
    • Tissue Plasminogen Activator
    • Anticoagulant
    • Antiplatelet
    • Antihypertensive

Diagnostics dominate the market

Diagnostics are crucial in accurately identifying and assessing strokes, enabling timely and effective treatment decisions. CT scans and MRIs are key diagnostic tools used to evaluate stroke patients. CT scans provide rapid imaging to detect bleeding or blockages in blood vessels, helping determine the type and location of the stroke. MRIs, on the other hand, offer detailed brain imaging, assisting in identifying ischemic areas and aiding in treatment planning. The increasing prevalence of strokes and the emphasis on early detection and intervention drive the demand for diagnostic tools, such as CT scans and MRIs.

Technological advancements in CT and MRI imaging, such as higher resolution, faster scanning times, and improved imaging protocols, have enhanced the accuracy and efficiency of stroke diagnosis. The diagnostics segment's growth is further fuelled by integrating artificial intelligence (AI) algorithms into imaging systems, enabling automated analysis and interpretation of imaging data. This streamlines the diagnostic process, expedites treatment decisions, and improves patient outcomes.

Breakup by Application:

  • Ischemic Stroke
  • Haemorrhagic Stroke

Ischemic Stroke holds the largest share of the market

Ischemic stroke is the most common type, caused by the blockage or narrowing of blood vessels supplying the brain, leading to reduced blood flow and oxygen delivery. The focus on ischemic stroke management drives themarket growth as it accounts for a substantial portion of stroke cases. The increasing incidence of ischemic stroke, often associated with risk factors like hypertension, diabetes, and a sedentary lifestyle, demands effective management strategies.

Advancements in ischemic stroke management, such as the development of thrombolytic drugs like tissue plasminogen activator (tPA) and mechanical thrombectomy procedures, have revolutionized treatment options. These interventions aim to restore blood flow to the affected area, minimize brain damage, and improve patient outcomes. The emphasis on ischemic stroke management is further supported by public health initiatives promoting stroke prevention, early recognition of symptoms, and rapid intervention. These initiatives propel the market by increasing awareness, encouraging individuals to seek medical help promptly, and implementing evidence-based management approaches.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Hospitals holds the largest share of the market

Hospitals play a critical role in stroke care, as they are the primary healthcare facilities for acute stroke treatment, specialized diagnostics, and rehabilitation services. The demand for stroke management solutions is propelled by hospitals' need to provide patients with comprehensive and specialized stroke care. As the burden of strokes rises, hospitals strive to enhance their capabilities in stroke diagnosis, treatment, and rehabilitation, impacting the market positively.

Hospitals invest in advanced imaging systems, neuro-interventional devices, and rehabilitation technologies to deliver optimal stroke care. They collaborate with stroke management companies and engage in clinical research to implement evidence-based practices and offer the latest treatment options. Furthermore, hospitals serve as centers for stroke education and training, disseminating knowledge to healthcare professionals regarding stroke prevention, early recognition, and appropriate management. This contributes to improved patient outcomes and raises awareness among the healthcare community, propelling the market.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America is a key market for stroke management due to several factors contributing to its growth and development. The region has a high prevalence of stroke cases, making it a significant market for stroke management solutions. The region's aging population, sedentary lifestyles, and high incidence of risk factors such as hypertension and obesity contribute to the increased burden of strokes. Furthermore, the region boasts advanced healthcare infrastructure and robust research and development capabilities. This enables the region to lead in developing and adopting innovative stroke management technologies, diagnostic tools, and treatment modalities.

Moreover, North America has a well-established healthcare system and reimbursement structure that supports the adoption of stroke management solutions. Favorable reimbursement policies and insurance coverage for stroke-related interventions and treatments drive the market. The presence of leading stroke management companies, healthcare providers, and research institutions in North America fosters collaboration, research, and advancements in stroke management practices. This contributes to the market growth by continually improving treatment outcomes and driving the adoption of new technologies and techniques.

COMPETITIVE LANDSCAPE:

Top stroke management companies are strengthening the market through their expertise, innovation, and commitment to improving patient outcomes. These companies invest heavily in research and development to develop cutting-edge technologies, devices, and pharmaceuticals for effective stroke prevention, diagnosis, treatment, and rehabilitation. Leading stroke management companies actively collaborate with healthcare providers, research institutions, and industry experts to drive innovation and stay at the forefront of stroke care. They conduct clinical trials and studies to gather evidence-based data and continuously improve their products and services. These companies are also crucial in raising awareness about stroke prevention and early intervention. They engage in educational initiatives, public health campaigns, and partnerships with patient advocacy groups to promote stroke awareness and provide resources to healthcare professionals and the general public. Moreover, top stroke management companies focus on delivering comprehensive solutions that encompass diagnostics, acute care, rehabilitation, and ongoing management. By offering integrated and patient-centric approaches, they strive to optimize patient outcomes and improve quality of life through their commitment to advancing stroke management practices.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the stroke management market?

2. What is the future outlook of the stroke management market?

3. What are the key factors driving the stroke management market?

4. Which region accounts for the largest stroke management market share?

5. Which are the leading companies in the global stroke management market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stroke Management Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computed Tomography Scan (CT Scan)
      • 6.1.2.2 Magnetic Resonance Imaging (MRI)
      • 6.1.2.3 Carotid Ultrasound
      • 6.1.2.4 Cerebral Angiography
      • 6.1.2.5 Electrocardiography
      • 6.1.2.6 Echocardiography
      • 6.1.2.7 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tissue Plasminogen Activator
      • 6.2.2.2 Anticoagulant
      • 6.2.2.3 Antiplatelet
      • 6.2.2.4 Antihypertensive
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Haemorrhagic Stroke
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GlaxoSmithKline plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Merck & Co. Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Stroke Management Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Stroke Management Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Stroke Management Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Stroke Management Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Stroke Management Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Stroke Management Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Stroke Management (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Stroke Management (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Stroke Management (Therapeutics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Stroke Management (Therapeutics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Stroke Management (Ischemic Stroke) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Stroke Management (Ischemic Stroke) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Stroke Management (Haemorrhagic Stroke) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Stroke Management (Haemorrhagic Stroke) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Stroke Management (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Stroke Management (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Stroke Management (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Stroke Management (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Stroke Management (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Stroke Management (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Stroke Management (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Stroke Management (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Stroke Management (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Stroke Management (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: North America: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: North America: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: United States: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: United States: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Canada: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Canada: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Asia-Pacific: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Asia-Pacific: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: China: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: China: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Japan: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Japan: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: India: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: India: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: South Korea: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: South Korea: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Australia: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Australia: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Indonesia: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Indonesia: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Others: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Others: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Europe: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Europe: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Germany: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Germany: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: France: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: France: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: United Kingdom: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: United Kingdom: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Italy: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Italy: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Spain: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Spain: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Russia: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Russia: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Others: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Others: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Latin America: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Latin America: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Brazil: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Brazil: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Mexico: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Mexico: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Middle East and Africa: Stroke Management Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Middle East and Africa: Stroke Management Market: Breakup by Country (in %), 2025
  • Figure 73: Middle East and Africa: Stroke Management Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Global: Stroke Management Industry: SWOT Analysis
  • Figure 75: Global: Stroke Management Industry: Value Chain Analysis
  • Figure 76: Global: Stroke Management Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stroke Management Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Stroke Management Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Stroke Management Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Stroke Management Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Stroke Management Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Stroke Management Market: Competitive Structure
  • Table 7: Global: Stroke Management Market: Key Players